Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acoltremon Symptom Tracking and Relief Assessment in Moderate-to-Severe Dry Eye Disease

NCT07268599 is registered in ClinicalTrials.gov with Colvard Kandavel Eye Center as lead sponsor.

NCT NCT07268599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07268599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acoltremon Symptom Tracking and Relief Assessment in Moderate-to-Severe Dry Eye Disease
Lead sponsor
Colvard Kandavel Eye Center
Phase
Observational
Overall status
Enrolling by invitation
Start date
November 24, 2025
Completion date
October 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye disease (ded)